Nanosensitizers for sonodynamic therapy for glioblastoma multiforme: current progress and future perspectives

Glioblastoma multiforme (GBM) is the most common primary malignant brain tumor, and it is associated with poor prognosis. Its characteristics of being highly invasive and undergoing heterogeneous genetic mutation, as well as the presence of the blood–brain barrier (BBB), have reduced the efficacy of...

Descripción completa

Detalles Bibliográficos
Autores principales: Guo, Qing-Long, Dai, Xing-Liang, Yin, Meng-Yuan, Cheng, Hong-Wei, Qian, Hai-Sheng, Wang, Hua, Zhu, Dao-Ming, Wang, Xian-Wen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9178901/
https://www.ncbi.nlm.nih.gov/pubmed/35676737
http://dx.doi.org/10.1186/s40779-022-00386-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9178901/
https://www.ncbi.nlm.nih.gov/pubmed/35676737
http://dx.doi.org/10.1186/s40779-022-00386-z

Ejemplares similares